Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice

Brain Research

Volumn 943, Issue 2, 2002, Pages 206-215

  Kaur, Gurpreet ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Algesia; Depression; Female mouse; Hyperphagia; Progesterone; Serotonergic agent

Indexed keywords

FLUOXETINE; NEUROSTEROID; PROGESTERONE; QUIPAZINE; SEGANSERIN; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN AGONIST; STEROID;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; EATING DISORDER; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HOT PLATE TEST; HYPERPHAGIA; HYPOPHAGIA; IMMOBILIZATION; MOOD DISORDER; MOUSE; NEUROMODULATION; NOCICEPTION; NONHUMAN; OVARY; PAIN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SWIMMING; TAIL FLICK TEST; TIME;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; FLUOXETINE; HYPERPHAGIA; MENSTRUAL CYCLE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; PIPERIDINES; PROGESTERONE; QUIPAZINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0037067788     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02624-0     Document Type: Article

References (47)

1. Abraham J.E. Nutritional factors in the etiology of the premenstrual tension syndromes. J. Reprod. Med. 28:(7):1983;446-464.
2. Amatayakul K., Sivasomboon B., Thanangkul O. A study of mechanism of weight gain in medroxyprogesterone acetate users. Contraception. 22:(6):1980;605-622.
3. Backstrom T. Symptoms related to the menopause and sex steroid treatments. Ciba Found. Symposium. 199:1995;171-180.
4. Bethea C.L., Gundlah C., Mirkes S.J. Ovarian steroid action in the serotonin neuronal system of macaques. Novartis Found. Symposium. 230:2000;112-133.
5. Chen S.W., Davies M.F., Loew G.H. Food palatability and hunger modulated effects of CGS 9896 and CGS 8216 on food intake. Pharmacol. Biochem. Behav. 51:1995;499-503.
6. Ciaramella A., Grosso S., Poli P. Fluoxetine versus fluvoxamine for the treatment of chronic pain. Min. Anestesiologia. 66:(1-2):2000;55-61.
7. Crammer J.L. Premenstrual depression, cortisol and estradiol treatment. Psychol. Med. 16:1986;451-455.
8. D'Armour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Therap. 72:1941;749-753.
9. Eddy N.B., Leimbach D. Synthetic analgesics. II Dithienyl butyenyl and dithienyl butylamines. J. Pharmacol. Exp. Ther. 107:1953;385-393.
10. Erjavec M.K., Coda B.A., Nguyen Q., Donaldson G., Risler L., Shen D.L. Morphine-fluoxetine interactions in healthy volunteers. Analgesia and side effects. J. Clin. Pharmacol. 40:(11):2000;286-295.
11. Frye C.A., Van Keuren K.R., Rao P.N., Erskine M.S. Analgesic effects of the neurosteroid 3 alpha-androstanediol. Brain Res. 709:(1):1996;1-9.
12. Fuller R.W. Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. Progress in Drug Res. 45:1995;167-204.
13. Ganesan R. The aversive and hypophagic effects of estradiol. Physiol. Behav. 55:(2):1994;279-285.
14. Gerardo-Gettens T., Moore B.J., Stern J.S., Horwitz B.A. Prolactin stimulates food intake in the absence of ovarian progesterone. Am. J. Physiol. 256:(3):1989;R701-R706.
15. Ho H., Olsson M., Westberg L., Melke J., Eriksson E. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats, an animal model of premenstrual irritability. Neuropsychopharmacology. 24:(5):2001;502-510.
16. Kaur G., Kulkarni S.K. Differential effect of polyherbal, antiobesity preparation, OB-200G in male and female mice and monosodium glutamate treated rats. Indian J. Exp. Biol. 39:2000;551-557.
17. Kaur G., Kulkarni S.K. Subchronic studies on modulation of feeding behavior and body weight by neurosteroids in female mice. Meth. Find. Exp. Clin. Pharmacol. 23:(3):2001;115-119.
18. Kaur G., Kulkarni S.K. Investigations on possible serotonergic involvement in the effects of OB-200G (polyherbal preparation) on food intake in female mice. Eur. J. Nutr. 40:(3):2001;127-133.
19. Kaur G., Kulkarni S.K. Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Progress Neuropsychopharmacol. Biol. Psychiatr. 26:2002;277-285.
20. Kulkarni S.K. Heat and other physiological stress-induced analgesia: catecholamines mediated and naloxone reversible response. Life Sci. 27:(3):1980;185-188.
21. Kulkarni S.K., Mehta A.K. Purine nucleosides-mediated immobility in mice: Reversal by antidepressants. Psychopharmacology. 85:1985;460-463.
22. Luine V.N., Wu V., Hoffman C.S., Renner K.J. GABAergic regulation of lordosis: influence of gonadal hormones on turnover of GABA and interaction of GABA with 5-HT. Neuroendocrinology. 69:(6):1999;438-445.
23. Malone D.T., Taylor D.A. Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Br. J. Pharmacol. 124:(7):1998;1419-1424.
24. Masqulier I., Saint Jean O., Bourdiol M.C., Boiffin A., Bouchon J.P. Bradycardia and hypothermia in an elderly patient receiving fluoxetine. Presse Med. 22:(11):1993;553.
25. Maswood N., Caldarola-Pastuszka M., Uphouse L. Functional interaction among the 5-hydroxytryptamine receptor families in the control of female rat sexual behavior. Brain Res. 802:(1-2):1998;98-103.
26. Matson S.C., Henderson K.A., McGrath G.J. Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females. J. Pediatric Adoles. Gynecol. 10:(1):1997;18-23.
27. Matuszczyk J.V., Larsson K., Eriksson E. Subchronic administration of fluoxetine impairs estrous behavior in intact female rats. Neuropsychopharmacology. 19:(6):1998;492-498.
28. Mayer L.E., Walsh B.T. The use of selective serotonin reuptake inhibitors in eating disorders. J. Clin. Psychiatry. 59:(1):1998;28-34.
29. 1A selective anxiolytics on lordosis behavior: interactions with progesterone. Eur. J. Pharmacol. 132:(2-3):1986;323-326.
30. Nayebi A.R., Hassapour M., Rezazadeh H. Effect of chronic and acute administration of fluoxetine and additive effect with morphine on the behavioral response in the formalin test in rats. J. Pharm. Pharmacol. 53:(2):2001;219-225.
31. Piette A.M., Darai E., Gepner P., Brousse C., Chapman A. A new cause of prolonged fever of unknown origin: progesterone substitution therapy. Presse Med. 23:(37):1994;1699-1702.
32. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
33. Post C., Minor B.G., Davies M., Archer T. Analgesia induced by 5-hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-depletion in rats. Brain Res. 363:(1):1986;18-27.
34. A and mitochondrial diazepam binding receptors in the antistress activity of neurosteroids in mice. Psychopharmacology. 128:1996;280-292.
35. Reddy D.S., Kulkarni S.K. The role of GABAA and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology. 137:1998;391-400.
36. 1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt Forced Swim test. Neuroreport. 9:1998;3069-3073.
37. Rutanen E.M., Teppo A.M., Stenman U.H., Tiitinen A., Fyhrquist F., Ylikorkala O. Recurrent fever associated with progesterone action and persistently elevated serum levels of immunoreactive tumor necrosis factor-alpha and interleukin-6. J. Clin. Endocrin. Metab. 76:(6):1993;1594-1598.
38. Sgaragli G., Carla V., Magnani M., Galli A. Hypothermia induced in rabbits by intracerebroventricular taurine: specificity and relationships with central serotonin (5-HT) systems. J. Pharmacol. Exp. Ther. 219:(3):1981;778-785.
39. Sherwin B.B. Progestogens used in menopause. Side effects, mood and quality of life. J. Reprod. Med. 44:(2):1999;227-232.
40. 2 receptor mediation in quipazine anorexia. Psychopharmacolgy. 100:(1):1990;115-118.
41. Sietnieks A., Meyerson B.J. Enhancement by progesterone of 5-hydroxytryptophan inhibition of copulatory response in the female rats. Neuroendocrinology. 35:(5):1982;321-326.
42. Silberstein S.D. Sex hormones and headache. Rev. Neurol. 156:(4):2000;4S30-4S41.
43. Voznesenskaia T.G., Safonova V.A., Platonova N.M. Disorders of eating behavior and comorbid syndromes in obesity and methods for their correction. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova. 100:(12):2000;49-52.
44. Wagner K.D., Berenson A.B. Norplant-associated major depression and panic disorders. J. Clin. Psychiatr. 55:1994;478-480.
45. Wallace J.M., Shively C.A., Clarkson T.B. Effects of hormone replacement therapy and social stress on body fat distribution in surgically postmenopausal monkeys. Int. J. Obes. 23:1999;518-527.
46. Wilcox B.D., Rydelek-Fitzgerald L., Jeffrey J.J. Regulation of uterine collagenase gene expression: interactions between serotonin and progesterone. Mol. Cell. Endocrinol. 101:(1-2):1994;67-75.
47. Zhang Y., Raap D.K., Garcia F., Serrus F., Ma Q., Battaglia G., Van de Kar L.D. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res. 855:(1):2000;58-66.